Cytogel Pharma

Darien, CT · Founded 2006 · Privately Held (backing)

Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain. Cytogel Pharma is based in Darien, CT and was founded in 2006. It was valued at $47 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $32.8 million across 4 recorded rounds; the latest was a $1.8 million seed round in Jun 2023.

PMV mark · valuation
$47.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$32.8M
Last round
Seed Round
Jun 2023
What is Cytogel Pharma worth?
$47.0MPrivateMarketView mark · Oct 2026

Valued at $47.0M at its later-stage round, Oct 2024. Nothing has traded since.

Free account
More of Cytogel Pharma with a free account
  • ·Watch Cytogel Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Cytogel Pharma funding history

4 rounds
DateRoundRaisedPost-money
Jun 2023Seed Round$1.8M▮
Sep 2019Seed Round$957K▮
Jan 2015Seed Round$2.7M▮
Feb 2013Seed Round$750K▮
Unlock post-money valuations

Membership and data by Private Market View

Cytogel Pharma valuation

Cytogel Pharma was valued at $47 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Cytogel Pharma raised?

Cytogel Pharma has raised $32.8 million in total; 4 of its rounds are on record, from 2013 on. The largest on record was a $956,905 seed round in Sep 2019; the most recent was a $1.8 million seed round in Jun 2023.

Cytogel Pharma has filed 14 Form Ds with the SEC since 2010, most recently in Oct 2024 ($1.8 million sold to 18 investors).

How Cytogel Pharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cytogel Pharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Cytogel Pharma

What is Cytogel Pharma worth?
Cytogel Pharma is valued at $47.0M as of Oct 2026. Valued at $47.0M at its later-stage round, Oct 2024. Nothing has traded since.
How much has Cytogel Pharma raised?
Cytogel Pharma has raised $32.8M in total funding across 4 recorded rounds.
When did Cytogel Pharma last raise?
Cytogel Pharma last raised in Jun 2023 (Seed Round), raising $1.8M.